Aquilon Pharmaceuticals (SA)

Active

VAT

BE 0540.870.218

Address

Rue Porte De Lorette(VIS) 76

4600 Visé

Established

14-10-2013

Principal activity

Research and experimental development on biotechnology

Try for free

Crisis resilience of Aquilon Pharmaceuticals

Which companies are best armed against current economic trends and the energy crisis?

2022		2021		2020		2019
Turnover	-	-	-	-	-	-	€1,213,083
Profit/Loss	-€762,477	-21%	-€629,068	-412%	€201,400	162%	-€324,974
Equity	€760,758	-50%	€1,523,235	-29%	€2,152,303	-16%	€2,561,600
Gross margin	€451,097	190%	€155,329	-93%	€2,332,566	> 1.000%	-€126,701
Employees	8,2 FTE	17%	7 FTE	49%	4,7 FTE	262%	1,3 FTE

Publications in the Belgian Official Journal for Aquilon Pharmaceuticals

Type	Date	Pdf	Subject
	14-11-2023		Capital, Shares (FR)
	17-02-2023		Articles of Association (Translation, Coordination, Other Modifications, …) - Capital, Shares - Resi… (FR)
	19-07-2022		Articles of Association (Translation, Coordination, Other Modifications, …) - Resignations, Appointm… (FR)
	18-12-2018		Capital, Shares - Resignations, Appointments (FR)
	01-09-2016		Resignations, Appointments (FR)

Sources

Frequently asked questions

What is the VAT number of Aquilon Pharmaceuticals?

The VAT number of Aquilon Pharmaceuticals is BE0540870218.

When was Aquilon Pharmaceuticals founded?

Aquilon Pharmaceuticals was founded on 14-10-2013.

What is the address of Aquilon Pharmaceuticals?

The current registered office of Aquilon Pharmaceuticals is located at Rue Porte De Lorette(VIS) 76, 4600 Visé.

When was the last time Aquilon Pharmaceuticals filed their annual financial statements?

The most recent financial statements of Aquilon Pharmaceuticals were filed on 10-07-2023. You can view them here.

How many employees does Aquilon Pharmaceuticals have?

There are 8,2 FTEs working at Aquilon Pharmaceuticals according to the staff figures in the most recent financial statements.

What is the annual turnover of Aquilon Pharmaceuticals?

At the time of its most recent financial statements, Aquilon Pharmaceuticals did not publish any turnover figures. Aquilon Pharmaceuticals reported a gross margin of €451,097.41.